Prognostic application of magnetic resonance imaging in patients with endometriomas treated with gonadotrophin-releasing hormone analogue
Magnetic resonance imaging T2SI/MSI ratios decreased significantly in good responders compared to poor responders after gonadotrophin-releasing hormone analogue treatment for endometriomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (13)
- Diagnosis of pelvic endometriosis by magnetic resonance imaging using "fat-saturation" technique via openalex
- Endometriosis: appearance and detection at MR imaging via openalex
- Medical Therapy of Endometriosis via openalex
- Pelvic endometriosis: MR imaging via openalex
- Revised American Fertility Society Classification of Endometriosis: 1985 via openalex
- The value of magnetic resonance relaxation time in staging ovarian endometrial cysts via openalex
- Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W2095593135 via openalex
- W2126235969 via openalex
- W2071563364 via openalex
- W2408619637 via openalex
- W1997312656 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:59:49.088203+00:00